- Home
- OTLK vs MLSS Comparison
OTLK vs MLSS Comparison
Compare OTLK & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OTLK | MLSS |
|---|---|---|
| Founded | 2010 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.8M | 23.7M |
| IPO Year | 2016 | 1995 |
Fundamental Metrics
Financial Performance| Metric | OTLK | MLSS |
|---|---|---|
| Price | $2.06 | $0.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $5.25 | $1.00 |
| AVG Volume (30 Days) | ★ 5.5M | 3.2M |
| Earning Date | 12-26-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,505,322.00 | ★ $8,929,517.00 |
| Revenue This Year | N/A | $8.95 |
| Revenue Next Year | $342.80 | $7.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.59 |
| 52 Week Low | $0.79 | $0.28 |
| 52 Week High | $3.39 | $1.39 |
Technical Indicators
Market Signals| Indicator | OTLK | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 69.44 | 49.10 |
| Support Level | $1.51 | $0.31 |
| Resistance Level | $2.10 | $0.32 |
| Average True Range (ATR) | 0.20 | 0.03 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 93.22 | 85.05 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.